Efficacy and Resistance of ALK Inhibitors in Two Inflammatory Myofibroblastic Tumor Patients with ALK Fusions Assessed by Whole Exome and RNA Sequencing

Efficacy and Resistance of ALK Inhibitors in Two Inflammatory Myofibroblastic Tumor Patients with ALK Fusions Assessed by Whole Exome and RNA Sequencing

Chenlu Zhang,1 Zhiming Wang,1 Rongyuan Zhuang,1 Xi Guo,1 Yi Feng,1 Feng Shen,1 Wenshuai Liu,2 Yong Zhang,3 Hanxing Tong,3 Wending Sun,4 Jun Liu,4 Guan Wang,4 Chun Dai,4 Weiqi Lu,3 Yuhong Zhou1 1Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, People’s Republi...

Full description

Bibliographic Details
Main Authors: Zhang C, Wang Z, Zhuang R, Guo X, Feng Y, Shen F, Liu W, Zhang Y, Tong H, Sun W, Liu J, Wang G, Dai C, Lu W, Zhou Y
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:OncoTargets and Therapy
Subjects:
inflammatory myofibroblastic tumor
crizotinib resistance
alectinib resistance
alk l1196q
sonic hedgehog pathway
Online Access:https://www.dovepress.com/efficacy-and-resistance-of-alk-inhibitors-in-two-inflammatory-myofibro-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/efficacy-and-resistance-of-alk-inhibitors-in-two-inflammatory-myofibro-peer-reviewed-article-OTT

Similar Items